{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10813558", "DateCompleted": {"Year": "2000", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "08"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0022-3573", "JournalIssue": {"Volume": "52", "Issue": "4", "PubDate": {"Year": "2000", "Month": "Apr"}}, "Title": "The Journal of pharmacy and pharmacology", "ISOAbbreviation": "J Pharm Pharmacol"}, "ArticleTitle": "Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.", "Pagination": {"StartPage": "451", "EndPage": "459", "MedlinePgn": "451-9"}, "Abstract": {"AbstractText": ["The effects of Ginkgo biloba leaf extract on rat brain or livermonoamine oxidase (MAO)-A and -B activity, biogenic amine concentration in nervous tissue, N-methyl-D-aspartate (NMDA)- and N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4)-induced neurotoxicity and antioxidant activity was investigated to determine the effects of the extract on monoamine catabolism and neuroprotection. Ginkgo biloba leaf extract was shown to produce in-vitro inhibition of rat brain MAO-A and -B. The Ginkgo biloba extract was chromatographed on a reverse-phase HPLC system and two of the components isolated were shown to be MAO inhibitors (MAOIs). These MAOIs were identified by high-resolution mass spectrometry as kaempferol and isorhamnetin. Pure kaempferol and a number of related flavonoids were examined as MAOIs in-vitro. Kaempferol, apigenin and chrysin proved to be potent MAOIs, but produced more pronounced inhibition of MAO-A than MAO-B. IC50 (50% inhibition concentration) values for the ability of these three flavones to inhibit MAO-A were 7 x 10(-7), 1 x 10(-6) and 2 x 10(-6) M, respectively. Ginkgo biloba leaf extract and kaempferol were found to have no effect ex-vivo on rat or mouse brain MAO or on concentrations of dopamine, noradrenaline, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Kaempferol was shown to protect against NMDA-induced neuronal toxicity in-vitro in rat cortical cultures, but did not prevent DSP-4-induced noradrenergic neurotoxicity in an in-vivo model. Both Ginkgo biloba extract and kaempferol were demonstrated to be antioxidants in a lipid-peroxidation assay. This data indicates that the MAO-inhibiting activity of Ginkgo biloba extract is primarily due to the presence of kaempferol. Ginkgo biloba extract has properties indicative of potential neuroprotective ability."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "CV Technologies, Edmonton, Alberta, Canada."}], "Identifier": [], "LastName": "Sloley", "ForeName": "B D", "Initials": "BD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Urichuk", "ForeName": "L J", "Initials": "LJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Morley", "ForeName": "P", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Durkin", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shan", "ForeName": "J J", "Initials": "JJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pang", "ForeName": "P K", "Initials": "PK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Coutts", "ForeName": "R T", "Initials": "RT"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Pharm Pharmacol", "NlmUniqueID": "0376363", "ISSNLinking": "0022-3573"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Kaempferols"}, {"RegistryNumber": "0", "NameOfSubstance": "Monoamine Oxidase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "102-32-9", "NameOfSubstance": "3,4-Dihydroxyphenylacetic Acid"}, {"RegistryNumber": "333DO1RDJY", "NameOfSubstance": "Serotonin"}, {"RegistryNumber": "54-16-0", "NameOfSubstance": "Hydroxyindoleacetic Acid"}, {"RegistryNumber": "6384-92-5", "NameOfSubstance": "N-Methylaspartate"}, {"RegistryNumber": "731P2LE49E", "NameOfSubstance": "kaempferol"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "EC 1.4.3.4", "NameOfSubstance": "Monoamine Oxidase"}, {"RegistryNumber": "VTD58H1Z2X", "NameOfSubstance": "Dopamine"}, {"RegistryNumber": "X4W3ENH1CV", "NameOfSubstance": "Norepinephrine"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "3,4-Dihydroxyphenylacetic Acid"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "enzymology", "metabolism"], "DescriptorName": "Brain"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dopamine"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Flavonoids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ginkgo biloba"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hydroxyindoleacetic Acid"}, {"QualifierName": [], "DescriptorName": "Kaempferols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Monoamine Oxidase"}, {"QualifierName": ["analysis", "pharmacology"], "DescriptorName": "Monoamine Oxidase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "N-Methylaspartate"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "Neurons"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Norepinephrine"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Leaves"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["analogs & derivatives", "analysis", "pharmacology"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serotonin"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "5", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "7", "Day": "15", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "5", "Day": "17", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10813558", "10.1211/0022357001774075"]}}], "PubmedBookArticle": []}